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Summary Well-characterized cell lines established from primitive neuroectodermal tumours (PNETs) were examined by proton nuclear
magnetic resonance ('H-NMR) spectroscopy and chromatographic analysis of perchloric acid extracts, following amplification in cell culture.
A characteristic 'H-NMR spectroscopic metabolite pattern was found for medulloblastoma cell lines, which clearly discriminates these cells
from PNETs of other locations in the central nervous system (CNS), on the basis of their N-acetyl aspartate (NM) and aspartate expression.
Medulloblastoma cell lines were heterogeneous in respect of their metabolite expression, possibly owing to the heterogeneity in their
differentiation along lineages of the CNS. All PNET spectra displayed similar features, including decreased NAA and creatine peaks and
increased signals from choline compounds (Cho) compared with normal cerebellum. The expression of NM by the medulloblastoma lines
was in the opposite order to the extent of neuronal differentiation, which may indicate their origin from a progenitor cell with the phenotype of
an oligodendrocyte-type-2 astrocyte cell.
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Primitive neuroectodermal tumours (PNETs) are highly malignant
[grade IV according to the World Health Organization classifica-
tion of brain tumours by Kleihues et al (1993)] and among the
most common tumours of childhood. They are most frequently
located in the cerebellum (i.e. cerebellar medulloblastomas), but
tumours that have a similar appearance and biological behaviour
have been found in other locations in the central nervous system
(CNS), such as the cerebrum, pineal region or spinal cord. The
nature and cell oforigin of these tumours, composed ofprimitive
or undifferentiated neuroepithelial cells, is controversial.
Questions have been raised as to whether their cell of origin is
unique to the portion of the CNS in which the tumour arises, or
whether there is a primitive or undifferentiated cell common to all
portions ofthe CNS. Rorke et al (1985) have suggested that these
tumours arise from a single primitive multipotential cell that has
the capacity to differentiate into one or more types ofneural cells -
such as astrocytes, oligodendrocytes, neurons, ganglion cells or
melanocytes - and are therefore regarded as malignant counter-
parts ofmultipotential neural progenitor cells.
Progress in understanding the cell biology ofthese tumours has
been hampered by the lack of cultured cell lines, since relatively
few continuous medulloblastoma lines have been established thus
far (Friedman et al, 1985; Jacobsen et al, 1985). However, the
recent establishment of five new human PNET cell lines from
surgical specimens (Pietsch et al, 1994) offers the opportunity to
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investigate the biology, phenotype, lineage and metabolism of
PNETs in detail. In the present study,metabolite profiles ofseveral
of these PNET cell lines in culture, together with two established
cell lines, were obtained. Perchloric acid extracts from samples
were analysed by proton nuclear magnetic resonance (1H-NMR)
spectroscopy and high-performance liquid chromatography
(HPLC). The aim was to detect similarities or differences in the
expression of specific metabolites by certain cell lines that could
aid in elucidating the issues addressed above.
MATERIALS AND METHODS
Preparation and analysis of cell cultures from human
PNET cell lines
Some of the cell lines we examined were generated from PNETs
of the cerebellum, i.e. from medulloblastomas: MHH-MED-1,
MHH-MED-3, MHH-MED-4, D283-MED and DAOY. MHH-
MED-3 and MHH-MED-4 were obtained from biopsies of cere-
bellar medulloblastomas, while MHH-MED-1 was generated
from cells recovered from the cerebrospinal fluid of a patient
with a recurrent cerebellar PNET that had seeded the cere-
brospinal fluid. D283-MED and DAOY were lines previously
established by Friedman et al (1985) and Jacobsen et al (1985).
Other cell lines (MHH-PNET-5 and MHH-PNET-6) were
obtained from PNETs of other locations in the CNS. MHH-
PNET-5 was obtained from a primary PNET located in the spinal
cord, while MHH-PNET-6 was obtained from a PNET with
disseminated growth in the CNS.
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The culture medium that was found to support efficiently the
growth of medulloblastoma cell lines by Pietsch et al (1994) was
Dulbecco's modified Eagle medium (DMEM), high-glucose
formulation (Gibco BRL,Paisley, UK) supplemented with 4 mM L-
glutamine (Sigma, Poole, UK) and 10% heat-inactivated, pretested
human umbilical cord serum. The cultures were grown without
antibiotics, and the culture medium was replaced every 3 days.
Protocols for cell harvesting, extraction and preparation of
samples have been described previously in full by Florian et al
(1995). Briefdetails are given here. Starting with 106 cells from the
stock for each individual cell line, cells were continuously carried
in culture until the amount necessary for high-resolution NMR was
obtained (typically 107-101 cells for a sample). Adherent cells
(from D283-MED, DAOY and MHH-MED-4 cell lines) were
harvested at 90-100% confluence. Cells growing in suspension
were harvested in the exponential phase at a maximum density of
5x105 cells ml-', to avoid cells inhibiting each other. Harvesting for
all cell lines was always performed 24 h after a final medium
change, and cell pellets were immediately frozen in liquid nitrogen.
As cerebellum is the normal host tissue for the tumours exam-
ined, one sample of human cerebellum was also analysed. The
difficulties in obtaining normal tissue from patients restricted us to
this single sample. Adjacent tissue was obtained from the resection
of a cerebellar vascular malformation from a 66-year-old female.
The tissue was snap frozen within 30 s from removal. Immuno-
cytochemical and histological analysis performed on the tissue
have shown no abnormalities.
Perchloric acid (PCA) extracts were prepared from the frozen
samples (cell pellets and frozen normal cerebellum). They were
lyophilized and resuspended in D20 in order to obtain the NMR
sample, to which an internal concentration and chemical shift stan-
dard was added. At least two PCA extracts were prepared for
every individual cell line (replicate samples), except forthe MHH-
MED-3 line (one sample).
1H-NMR spectroscopy
Spectra were recorded at 26-300C on a Varian Unity-plus NMR
spectrometer (Varian Associates, NMR Instruments, Palo Alto,
CA, USA) operating at a proton frequency of 500 MHz. Single-
pulse spectra (approaching full relaxation) were acquired with
450 pulses applied every 5 s, with presaturation of the residual
water signal.
Metabolite peaks in IH-NMR spectra were identified by: (1)
their chemical shift and coupling pattern as described in the litera-
ture by Cerdan et al (1985), Sze et al (1990) and Preece et al
(1993); (2) comparison with spectra of metabolites in known
concentrations obtained at the same pH and spectroscopic condi-
tions; (3) two-dimensional spectroscopic methods according to
Florian et al (1995). Metabolite amounts were calculated from their
intensities in 'H-NMR spectra, by reference to the internal standard
3-trimethylsilyl-tetradeuterosodium propionate (TSP) after base-
line correction. The intensity of a given signal in the proton spec-
trum is proportional to the concentration of the compound in the
sample and to the number ofprotons contributing to each signal.
HPLC analysis of metabolites
Quantitative determination of amino acids, N-acetylaspartate
(NAA) and N-acetylaspartylglutamate (NAAG) was performed by
HPLC to complement the spectroscopic data, using methods that
have already been described by Florian et al. (1995). Amino acids
were analysed by derivatization with O-phtaldialdehyde according
to Lindroth and Mopper (1979), the concentrations being calcu-
lated from external standards. NAA was analysed by a method
previously described by Urenjak et al (1993). Detection forNAAG
was carried out using an Anachem SAX (46 mm internal diameter,
25 cm length) column fitted with a 1-cm guard column, according
to Koller et al (1984).
Data processing and statistics
The amounts ofmetabolites determined in each sample were refer-
enced to the amount of protein in the sample [determined by the
bicinchoninic acid method of Smith et al (1985)], and they are
expressed as nmol mg-' protein. The results fromreplicate samples
of one to three extracts for a cell line were averaged for all cell
lines considered within a category of tumour (i.e. lines derived
from tumours of the cerebellum, MHH-MED and lines derived
from PNETs of other locations in the CNS, MHH-PNET - see
Results for more details). Results are presented as means±s.d.
One-way analysis of variance (ANOVA) was performed to
determine significant differences among group means, and P-
values are quoted without correction for multiple comparisons.
The critical values for assessing significance levels were obtained
after performing a Bonferroni correction for multiple comparisons
as described by Altman (1991) independently for NMR and HPLC
data sets (10 and 12 comparisons respectively) from the cell line
samples. These critical values are P<0.005 for a 5% significance
level (i.e. 0.05/10 or 0.05/12), and P<0.001 for a 1% significance
level (analogous).
RESULTS
The cell lines examined can be divided into two broad classes
based on the location in the CNS ofthe original tumour, and ofthe
morphological and immunocytochemical features of the cell line.
One category (MHH-MED) includes tumours of the cerebellum
(medulloblastomas): MHH-MED-1, MHH-MED-3, MHH-MED-4
and D283-MED. Another category (MHH-PNET) included PNETs
of other locations in the CNS, MHH-PNET-5 and MHH-PNET-6.
The DAOY medulloblastoma cell line was considered separately,
as it has unusual growth characteristics and an atypical immuno-
phenotype. Data from these cell lines were alsocompared with data
from one sample ofnormal human cerebellum, although statistical
analysis could not be performed on results from a single sample.
Figure 1 shows representative spectra from each category ofcell
lines examined, and from the normal cerebellum. Quantitative data
are given in Table 1 (from NMR spectra) and Tables 2 and 3
(HPLC determinations). Table 3 presents values for NAA and y-
aminobutyric acid (GABA) from replicate samples of a given
cell line.
The NMR profiles and metabolite concentrations in replicate
preparations of a cell line were highly reproducible. Spectra from
cell lines within the same category of tumour were qualitatively
similar, i.e. they contained the same detectable peaks. A more
complex pattern of metabolite signals, of medium to high inten-
sity, in the region 3.2-4.0 p.p.m. was characteristic of 'H-NMR
spectra from MHH-PNET cell lines compared with spectra from
the other categories of PNETs and of normal cerebellum. In addi-
tion to the assigned metabolites, there were several unidentified
signals in the spectra from PNET cell lines (with the exception of
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Figure 1 Representative high-field regions of 1H-NMR spectra of acid-soluble metabolites from human cerebellum and from categories of human PNETs.
Spectra were obtained from PCA extracts of human cerebellum (A), and from cell lines of human primitive neuroectodermal tumours. Spectra from the following
cell lines are displayed: DAOY (B), MHH-MED-4 (C) and MHH-PNET-6 (D). NMR spectroscopic analysis was performed at pH 8.9, with 512 scans recorded on
a spectrometer operating at the proton frequency of 500 MHz. Typically, 107-108 cells were obtained for one extract. The content in protein of samples from
PNET cell lines ranged from 0.32 mg to 1.93 mg. Spectra were referenced to TSP (0 p.p.m.). The following metabolites were identified from their strongest and
best resolved resonances (see text also): P-hydroxybutyrate (p-HB) -yCH3 1.2 p.p.m. (doublet); threonine -yCH3 1.3 p.p.m. (doublet); lactate -CH3 1.34 p.p.m.
(doublet); alanine - CH3 1.47 p.p.m. (doublet); acetate - CH3 1.92 p.p.m. (singlet); N-acetyl-aspartate (NM) - NCOCH3 2.02 p.p.m. (singlet); N-acetyl-aspartyl-
glutamate (NAAG) - NCOCH3 2.05 p.p.m. (singlet); glutamate -yCH2 2.34 p.p.m. (triplet); succinate - CH2 2.41 p.p.m. (singlet); glutamine -yCH2 2.44 p.p.m.
(triplet); aspartate - CH2 2.56 and 2.75 p.p.m. (two doublets); creatine - NCH3 3.04 p.p.m. (singlet); taurine -SCH2 3.08 p.p.m. and -NCH2 3.42 p.p.m.
(triplets); choline - N(CH3)3 3.21 p.p.m. (singlet); phosphorylcholine (PC) - N(CH3)3 3.22 p.p.m. (singlet); glycerophosphorylcholine (GPC) - N(CH3)3 3.23 p.p.m.
(singlet); glycine - CH2 3.56 p.p.m. (singlet); myo-inositol (Ino) (H2) 4.05 p.p.m. (triplet)
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Table 1 Comparative composition of metabolites quantified from 'H-NMR spectra of PNET cell lines and from the sample of normal human cerebellum
Metabolites (nmol mg-' protein) MHH-PNET MHH-MED DAOY Pvalue HCB
Alanine 38.2 ± 18.9 25.5± 10.0 36.1 ± 0.1 0.150 21.1
Cho 21.8 ± 4.5 46.6 ± 23.8 31.1 ± 1.4 0.071 28.9
Creatine 9.7± 11.1 30.7 ± 25.6 28.4± 3.1 0.145 147.5
Glutamate 155.1 ± 74.3 136.2 ± 61.8 74.4 ± 0.3 0.590 191.9
Glycine 83.2 ± 65.1 81.6 ± 68.7 43.0 ± 1.3 0.968 30.5
Inositol 41.5 ± 54.3 50.4 ± 35.6 12.0 ± 0.3 0.691 42.9
Succinate 20.4 ± 6.6 18.4 ± 6.0 13.9 ± 2.3 0.567 27.1
Threonine 45.7 ± 15.8 30.2 ± 25.3 14.0 ± 1.9 0.273 1.2
Spectra obtained from replicate preparations for each of the cell lines (independent observations) of each category of PNET were analysed by reference to TSR
Metabolite concentrations (nmol mg-1 protein) obtained from replicate samples from a cell line within a category of tumour were averaged per category of
tumour and expressed as means ± s.d. One-way ANOVA tests were carried out (MHH-PNET vsMHH-MED), and P-values are given without correction for the
number of comparisons. The results for one category of PNET were considered statistically different from the results of the category compared if P<0.05/12 (5%
level) or P<0.01/12 (1% level). HCB, human cerebellum.
Table 2 Comparative composition of metabolites quantified by HPLC analysis of PCA extracts from PNET cell lines and from the sample of normal human
cerebellum
Metabolite (nmol mg-' protein) MHH-PNET MHH-MED DAOY PLvalue HCB
Alanine 42.4 ± 16.2 29.9 ± 9.0 38.7 ± 1.5 0.108 20.7
Arginine 9.53 ± 8.0 4.4 ± 1.4 4.1 ± 1.3 0.081 2.3
Asparagine 11.9 ± 1.7 101 ± 7.2 45.2 ± 0.8 0.557 1.9
Aspartate 73.6 ± 7.5 18.1 ± 5.2 22.3 ± 2.1 <0.001* 18.3
GABA 1.0 ± 0.3 1.2±1.4 1.8 ± 0.0 0.545 23.4
Glutamine 162.1 ± 25.9 100.1 ± 87.0 0.21 ± 0.29 0.098 68.4
Glutamate 157.8 ± 24.7 136.9 ± 73.7 70.5 ± 0.6 0.802 144.4
Hypotaurine 14.2 ± 2.2 5.6 ± 7.0 9.4 ± 0.4 0.032 ND
NAA 0.81 ± 1.5 11.3±6.5 15.5±1.6 0.004* 95.2
NAAG ND 5.8 ± 6.2a 8.5 ± 0.9 0.055 15.8
Serine 38.9 ± 14.2 19.5 ± 8.3 28.2 ± 7.3 0.012 10.2
Taurine 28.0 ± 9.4 55.2 ± 32.5 45.9 ± 5.0 0.305 37.1
Tyrosine 2.6 ± 0.9 9.7 ± 6.9 2.8 ± 0.6 0.310 4.9
Metabolite concentrations (nmol mg-1 protein) from replicate samples of a cell line were averaged per category of tumour considered, being expressed as
means ± s.d. One-way ANOVA tests were carried out (MHH-PNET vs MHH-MED), and P-values are given without correction for the number of comparisons.
The results for one category of PNET were considered statistically different from the results of the category compared if P<0.05/12 (*5% level) or P<0.01/12
(**1% level) aNMG amounts were considered 0 in the medulloblastoma cell lines (MHH-MED-3 and D283-MED) in which they were below the limit of detection
by HPLC. ND, not detected (below the limit of detection).
Table 3 Expression of NAA and GABA by individual replicate samples of the medulloblastoma cell lines MHH-MED (MHH-MED-1, MHH-MED-3, MHH-MED-4
and D283-MED)
MHH-MED cell line NAA GABA
Values from replicate samples Average per cell line Values from replicate samples Average per cell line
MHH-MED-1 11.5; 15.0; 11.9 12.8 ±11.9 3.37; 1.23; 3.55 2.71 ± 1.29
MHH-MED-3 10.3 N 0.3 N
MHH-MED-4 17.2; 21.4 19.3 ± 3.0 0.12; 0.12 0.12 ± 0.0
D283-MED 2.87; 2.92 2.9 ± 0.03 1.57; 1.50 1.54 ± 0.05
Metabolite concentrations, determined by HPLC, were given in nmol mg-' protein. The number of replicate samples were: n = 3 for MHH-MED-1; n = 1 for
MHH-MED-3; n =2 for MHH-MED-4 and n=2 for D283-MED.
DAOY). These included a doublet with the chemical shift of 1.14
p.p.m., a singlet signal at 1.28 p.p.m. overlapping with the doublet
from threonine (1.30 p.p.m.) and a singlet at 3.4 p.p.m. Further
investigations as to the nature of these resonances by NMR were
unable to provide enough information for their identification.
Spectra were also obtained from the culture media used to support
the growth ofthe PNET cell lines (lyophilized andresuspended in
D20), and neither ofthe unidentifiedpeaks in the spectra from cell
lines was displayed in the spectra from the culture media (spectra
not shown).
There were some characteristics in the spectra from all PNET
cell lines,including the presence ofsignals fromvaline,leucine and
isoleucine (0.9-1.5 p.p.m.), threonine, lactate, alanine and acetate.
All tumour NMR profiles displayed signals from glutamate and
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succinate in the methylene region (2-3 p.p.m.), and from choline-
containing compounds (Cho), glycine and inositol further down-
field. Spectra from all MHH-PNET cell lines and from
MHH-MED-3 and MHH-MED-4 contained glutamine peaks, while
signals from this compound were absent in spectra from DAOY,
MHH-MED-1 and D283-MED.
In the class of medulloblastomas (MHH-MED) consisting of
four cell lines it was evident that the expression of individual
metabolites was quite variable from cell line to cell line. The
greatest variations were for NAA (approximately 10 times),
GABA (approximately 30 times), glutamine (approximately 150
times). NAAG was below the limit ofdetection by HPLC determi-
nations (0.1 nmol) in MHH-MED-3 and D283-MED, while the
other two cell lines contained detectable amounts of NAAG
(8.8±1.2 nmol mg-' protein in MHH-MED-1 and 14.5+0.4 nmol
mg-' protein in MHH-MED-4).
'H-NMR spectra from all tumour cell lines exhibited differences
compared with the spectrum from human cerebellum (Figure 1).
There was a marked decrease in the signals from NAA (2.02
p.p.m.), which were low or notNMR visible in spectra from most of
the cell lines. Detectable NAA and NAAG (2.05 p.p.m.) signals (of
low intensity) were present in spectra from DAOY. Lower, but still
detectable, NAA signals were displayed by spectra from all medul-
loblastoma cell lines, whereas they were absent in spectra from
PNETs of other locations in the CNS. These qualitative spectral
features were reflected inthe HPLC determinations thatrevealedthe
highest NAA content in MHH-MED-4 and DAOY cell lines (Table
3). The amount of NAA in MHH-MED cell lines decreased in the
orderMHH-MED-4,MHH-MED-1,MHH-MED-3, D283-MED. A
statistically significant difference in the NAA concentrations (5%
level) was obtained in the MHH-PNETcell lines compared with the
category ofcell lines derived from medulloblastomas.
The most prominent peaks in the spectrum from normal human
cerebellum were creatine and NAA, which were both compara-
tively reduced in NMRprofiles from tumourlines. Chopeaks were
prominent in tumour spectra, and there was an inversion of the
relative intensities of the creatine and Cho peaks compared with
normal tissue (from creatine>Cho in normal cerebellum to
Cho>creatine in all tumours).
Signals from metabolites, such as aspartate, GABA (2.3 p.p.m.,
triplet), taurine and hypotaurine (2.65 p.p.m. and 3.3 p.p.m.,
triplets) were too low to be quantified accurately in NMR spectra.
MHH-PNET cell lines contained higher amounts ofaspartate than
the normal cerebellum. There were statistically significant differ-
ences (1% level) in the aspartate content between PNET cell lines
from other locations in the CNS than cerebellum (MHH-PNET)
and the medulloblastomas.
The concentration of GABA (HPLC analysis) in the PNET cell
lines was much lower (approximately 10 times to approximately
100 times) than in the normal cerebellum (Table 2). The highest
amounts ofthis neuroactive amino acid were expressed by the cell
lines MHH-MED-1 and D283-MED (Table 3), while MHH-MED-
4 cell line contained the lowest amount ofGABA.
There were no statistically significant differences in the
amounts ofalanine between preparations from the cell lines exam-
ined, and the values for alanine concentration in tumours were
similar to the value in normal cerebellum (bothquantification from
spectra andby HPLC,Tables 1 and 2). Spectra from all tumourcell
lines displayed medium-intensity signals of threonine (1.3 p.p.m.,
doublet), as opposed to low threonine peaks in the spectrum from
normal cerebellum.
DISCUSSION
Our analysis by 'H-NMR spectroscopy and HPLC of the metabo-
lite composition of PNET-derived cell lines of the human CNS
have yielded the finding that 'typical' medulloblastoma lines
(derived from cerebellar tumours) differ in several respects from
PNETs derived from outside the cerebellum. The clearest features
were in the expression ofNAA and aspartate.
The relationship between medulloblastomas of the cerebellum
and PNETs of other regions in the CNS is controversial, owing to
the still unresolved problem of histogenesis of the cerebellar
medulloblastoma, as pointed out by Kleihues et al (1993). The
possibility that all PNETs arise from a single primitive multipoten-
tial cell population believed to be the subependymal layer, which
has the capacity to differentiate into one or more types of neural
cells, such as astrocytes, oligodendrocytes, neurons,ganglion cells
or melanocytes, has been raised by Rorke et al (1985). Further
immunohistochemical and histological investigations performed
by Cruz-Sanchez et al (1989) have demonstrated that differentia-
tion in the medulloblastomas occurs along two lines: glial and/or
neuronal. The observations of Burger et al (1987) and Cudkowitz
and De la Monte (1989) suggest that the trend is predominantly
towards neuronal rather than glial differentiation. The fact that
medulloblastomas express neuronal but no glial-specific markers
has been confirmed in studies on experimental mice PNETs of
other locations in the CNS carried out by Fung et al (1994).
Investigations by Trojanowski et al (1992, 1994) have revealed
that, in fact, neoplastic cells in PNETs exhibit molecular defects in
the sequence of maturational events leading to the exit of stem
cells or partially committed neuron-like precursors from the cell
cycle, followed by their terminal differentiation into neurons, and
therefore they partially recapitulate stages in the maturation of
normal human CNS progenitor cells (neuroblasts).
In the context of these issues, the present study revealed a
considerable heterogeneity in the expression of a number of
metabolites across the medulloblastoma cell lines examined. This
was in contrast to the relatively tight distribution of the corre-
sponding metabolites (variation up to a factor of 5) reported by
Florian et al (1996) in differentcell lines comprising well-differen-
tiated brain and nervous system tumours (either neuroblastomas,
glioblastomas or meningiomas). An explanation for this may
reside in the several degrees and directions of commitment in
differentiation towards various lineages of the CNS of the medul-
loblastoma cells examined here. According to their immuno-
phenotype, the lines studied represent various stages of
neuronal differentiation, D283-MED being the most advanced.
MHH-MED-3 has an 'early neuronal' phenotype, while MHH-
MED-1 and MHH-MED-4 are rather undifferentiated (Pietsch
et al, 1994). It is difficult to estimate whether, or to what
extent, metabolite expression in cell extracts would be influenced
by cell confluence or density at harvest, for cells growing in
suspension. Previous experiments have shown that the metabolite
expression in adherent cells is consistent, provided the culture and
harvesting conditions are maintained constant (C Florian, unpub-
lished observations).
Among the cell lines studied, there were some that displayed
detectable signals from NAA, a metabolite regarded as a neuronal
marker (Gill et al, 1990; Urenjak et al, 1992). The cell lines MHH-
MED-4 and DAOY expressed the highest amounts of NAA,
although, as shown by Pietsch et al (1994), they lack features and
markers (i.e. neurofilaments) of terminal neuronal commitment.
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Within the category of cell lines derived from PNETs ofthe cere-
bellum (medulloblastomas) (excluding DAOY), the relative
amounts of NAA in the cell lines that expressed it (MHH-MED-
4>MHH-MED-l>MHH-MED-3>D283-MED) was in the oppo-
site order to the extent of neuronal differentiation apparent from
their immunophenotypic features (D283-MED>MEH-MED-
3>MHH-MED-1 and MHH-MED-4) found by Pietsch et al
(1994). Although the number of replicates for each cell line was
small, the NAA and GABA levels in a given cell line were repro-
ducible, and we are confident they represent real differences rather
than chance variations. Cell lines derived from PNETs of other
locations in the CNS than cerebellum did not express NAA (unde-
tectable in the NMR spectra and under the limit of detection by
HPLC determinations). There does not seem to be any positive
correlation between the presence of NAA in these lines revealed
by the present study and the absence of advanced neuronal
features or neuronal channels in these cell lines as suggested by
other investigations (T Pietsch, unpublished observations).
NAA was one ofthe key compounds in assigning cell lineage in
our previous work, which has been found by Urenjak et al (1992)
in significant concentrations in oligodendrocyte-type-2 astrocyte
(0-2A) progenitor cells and in neurons. Additionally, Urenjak et al
(1993) have found that the qualitative and quantitative differences
between 'H-NMR spectra obtained from different purified popula-
tions of neural cells appears to be strongly correlated with the
lineage ofthe cell type examined. In this respect, the higher levels
ofNAA found in less-differentiated PNETs and specifically in the
PNETs of cerebellar origin (i.e. medulloblastomas) in this study
are confusing. It is not yet known whether, or at what levels,
neuronal progenitor cells express NAA. Although NAA levels
increase in the rat CNS during post-natal development and matura-
tion, as shown by Miyake and Kakimoto (1981) and Bates et al
(1989), the relative contribution ofthe neuronal and 0-2A lineages
to this rise is unclear. Therefore, it is not possible to say whether
the NAA levels observed in PNET cell lines are typical ofdividing
neuronal progenitors of the cerebellum. There is a possibility that
the expression ofNAA by medulloblastomas reflects, in fact, their
origin from a progenitor cell with the phenotypic characteristics of
an 0-2A progenitor cell, rather than of a neuronal progenitor.
Nonetheless, the highly significant differences in NAA levels
between cerebellar medulloblastomas and PNETs from other CNS
locations may suggest differences in lineage origin for these
tumours, as well as differences from other tumours of the CNS,
which have been studied by Florian et al (1995, 1996).
A lack of correlation was also found in the expression of NAA
and of GABA, and in the expression of GABA and the degree of
neuronal differentiation by the medulloblastoma cell lines.
Although high concentrations of the neuroactive amino acid
GABA seem to be a specific attribute of neurons compared with
other cell types ofthe brain as found by Urenjak et al (1993), in the
present study the highest concentrations of GABA were found in
MHH-MED-I and D283-MED, whereas cell lines, such as MHH-
MED-3 and -4, expressed the lowest amounts ofGABA.
The above differences need to be recognized in the context of
many similarities between the cell lines examined. The 'H-NMR
profiles obtained from all PNET cell lines displayed common
features irrespective of their location in the CNS, immunopheno-
typical features or growth characteristics. Such similarities were
prominent signals from Cho, low or undetectable signals from
NAA, NAAG or GABA, and a reduced creatine signal compared
with Cho peaks. These findings were consistent with the outcome
of investigations by 'H-NMR spectroscopy on various types of
human CNS tumours by Bruhn et al (1989), Kotitschke et al
(1994) and Remy et al (1994), revealing that gliomas (astrocy-
tomas and glioblastoma multiforme), meningiomas and neuri-
nomas display a decrease in signals from NAA, GABA and
creatine, and an increase in Cho peaks compared with normal
brain. The characteristics of the spectrum obtained from the
sample of normal cerebellum were consistent with studies by
localized 'H-NMR spectroscopy of human brain carried out by
Frahm et al (1990) and Bruhn et al (1989).
It is necessary to point out that, despite lineage specificity of
NAA expression in CNS cells, there were unidentified common
peaks found in IH-NMR spectra from the cell lines ofboth medul-
loblastomas and PNETs of other regions of the CNS. Until the
metabolites have been identified that are responsible for gener-
ating these peaks, which cannot be accounted for by the culture
medium, it is difficult to comment on their relevance to lineage-
specific cell type recognition by 'H-NMR spectroscopy.
In conclusion, the results ofthis study suggest that medulloblas-
toma cell lines have a characteristic metabolite pattem detectable
by 'H-NMR spectroscopy. This pattem discriminates cerebellar
medulloblastomas from PNETs of other locations in the CNS,
from normal cerebellum and from other brain tumours.
To ourknowledge, this study is probably one ofthe first investi-
gations by 'H-NMR spectroscopy on cell lines derived from
human PNETs. No reference was found in the literature to studies
using 'H-NMR spectroscopy on human PNETs, either in vivo or in
vitro. The difficulties associated with studies in vitro such as this
reside in establishing cell lines derived from specimens ofPNETs,
and in the maintenance and efficient continuous growth of such
cell lines. Further studies on the metabolite profiles offresh tumour
samples from posterior fossa tumours of childhood of different
degrees ofdifferentiation and malignancy, such as pilocytic astro-
cytoma, haemangioblastoma, ependymoma, glioblastoma and
medulloblastoma, will elucidate clinically the value ofthis method
forthese common childhood tumours, which represent adiagnostic
problem before biopsy. In addition, we hope that it will be possible
to develop an improved non-invasive NMR-based diagnostic tool
in vivo,especially fortumours in locations in which biopsy is diffi-
cult and dangerous, such as brain stem tumours.
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